表紙
市場調查報告書
商品編碼
1028006

Eubiotics的全球市場:未來預測 (2021年∼2028年)

Global Eubiotics Market Forecast 2021-2028

出版日期: | 出版商: Inkwood Research | 英文 244 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球Eubiotics的市場規模,在預測期間內 (2021年∼2028年) 預計以7.11%的年複合成長率成長。市場主要促進因素,是動物健康的認識和關心高漲,加工種子的需求增加,肉品消費量增加等。

在各地區中,在亞太地區的預計大幅度成長。其要素是發展中國家的所得提高,肉消費量大幅增加,顯著的生活方式的變化等。

本報告提供全球Eubiotics的市場相關分析,市場基本結構和主要的促進、阻礙因素,市場規模趨勢預測,各產品、各形狀、各包裝型態、家畜、各用途及各地區詳細趨勢,市場競爭趨勢,主要企業的簡介 (企業概要,主要產品/服務,事業策略及其他) 等相關調查。

目錄

第1章 分析範圍、手法

第2章 摘要整理

第3章 市場動態

  • 主要的推動市場要素
    • 動物健康相關意識的高漲與疑慮
    • 肉類的消費量增加
    • 對加工飼料的需求增加
  • 主要的阻礙市場要素
    • Eubiotics的知名度低

第4章 主要分析

  • COVID-19對Eubiotics市場的影響
  • 市場主要趨勢
  • 波特的五力分析
  • 市場機會矩陣
  • 業者情勢

第5章 各產品的市場

  • 益生菌
  • 有機酸
  • 益生元
  • 精油

第6章 各形狀的市場

  • 固體/乾燥
  • 液體

第7章 各包裝型態市場

  • 散裝包裝
  • 自立袋/部分控制 (個體包裝)

第8章 各家畜市場

  • 家禽
  • 反芻動物
  • 養殖魚
  • 其他家畜

第9章 各用途的市場

  • 腸的健康
  • 免疫
  • 產量管理
  • 其他的用途

第10章 各終端用戶的市場

  • 動物

第11章 各地區的分析

  • 北美
    • 市場規模、估計
    • 主要的促進因素
    • 主要課題
    • 主要企業
    • 各國分析
  • 歐洲
  • 亞太地區
  • 其他的國家 (RoW)

第12章 競爭情形

  • 主要策略的發展趨勢
    • 企業合併、收購 (M&A)
    • 產品的銷售
    • 夥伴關係、契約
    • 事業擴大
  • 企業簡介
    • ANPARIO PLC
    • ARCHER DANIELS MIDLAND CO (ADM)
    • BASF SE
    • BEHN MEYER GROUP
    • BENEO GMBH
    • CARGILL INC
    • CHR HANSEN HOLDING A/S
    • DUPONT DE NEMOURS INC
    • KEMIN INDUSTRIES INC
    • KONINKLIJKE DSM NV
    • LALLEMAND INC
    • LESAFFRE
    • NEOSPARK DRUGS AND CHEMICALS PRIVATE LIMITED
    • NOVUS INTERNATIONAL INC
    • YARA INTERNATIONAL ASA
目錄
Product Code: 40345

KEY FINDINGS

The global eubiotics market is anticipated to register a CAGR of 7.11% over the forecasting period of 2021 to 2028. The market growth is attributable to factors such as the increasing awareness and concerns about animal health, the rising demand for manufactured seeds, and the growing meat consumption.

MARKET INSIGHTS

Eubiotics are feed additives constituting prebiotics, essential oils, probiotics, and organic acids. They can successfully help facilitate gut health with or without a significant reduction in the use of antibiotic growth promoters (AGPs). Moreover, the term eubiosis refers to an ideal balance of microflora in the gastrointestinal system.

Animal disease outbreaks on account of animal slaughter, trade halts, and subsequent disease eradication efforts can cost a nation millions of dollars. For instance, PRRSV, a virus that causes stillborn piglets, costs the United States' farmers an annual $600 million. Animal disorders with human health implications can significantly affect aspects such as global trade, public health, as well as the stability of the economy's agricultural segment. Furthermore, healthy animals are more likely to lead to safer food supplies, higher farm productivity, including elevated numbers of offspring, minimal environmental impact, and enhanced animal welfare.

REGIONAL INSIGHTS

The global eubiotics market growth is evaluated across the Asia-Pacific, Europe, North America, and the Rest of World. The Asia-Pacific is set to progress with the highest CAGR during the forecasting years, owing to factors such as income development in developing countries, the considerable rise in meat consumption, and notable lifestyle changes.

COMPETITIVE INSIGHTS

Companies with undistinguishable products and more extensive portfolios generate intense competition within the global eubiotics market. They also spend millions of dollars on expanding their product portfolios. In addition, several firms are introducing new products into the market, thus ensuring the availability of alternatives. As a result, industrial rivalry is high across the global eubiotics market.

Some of the top enterprises operating in the market are: Cargill Inc, DuPont de Nemours Inc, Archer Daniels Midland Co (ADM), etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. RISING AWARENESS AND CONCERNS ABOUT ANIMAL HEALTH
    • 3.1.2. INCREASED MEAT CONSUMPTION
    • 3.1.3. INCREASED DEMAND FOR MANUFACTURED FEEDS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. UNAWARENESS ABOUT EUBIOTICS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON EUBIOTICS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY PRODUCT

  • 5.1. PROBIOTICS
  • 5.2. ORGANIC ACID
  • 5.3. PREBIOTICS
  • 5.4. ESSENTIAL OILS

6. MARKET BY FORM

  • 6.1. SOLID FORM/DRY FORM
  • 6.2. LIQUID

7. MARKET BY PACKAGING

  • 7.1. BULK PACKAGING
  • 7.2. STAND-UP POUCHES/PORTION CONTROL

8. MARKET BY LIVESTOCK

  • 8.1. SWINE
  • 8.2. POULTRY
  • 8.3. RUMINANTS
  • 8.4. AQUACULTURE
  • 8.5. OTHER LIVESTOCK

9. MARKET BY APPLICATION

  • 9.1. GUT HEALTH
  • 9.2. IMMUNITY
  • 9.3. YIELD MANAGEMENT
  • 9.4. OTHER APPLICATIONS

10. MARKET BY END-USER

  • 10.1. ANIMALS
  • 10.2. HUMANS

11. GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1. MARKET SIZE & ESTIMATES
    • 11.1.2. KEY DRIVERS
    • 11.1.3. KEY CHALLENGES
    • 11.1.4. KEY PLAYERS
    • 11.1.5. COUNTRY ANALYSIS
      • 11.1.5.1. UNITED STATES
      • 11.1.5.2. CANADA
  • 11.2. EUROPE
    • 11.2.1. MARKET SIZE & ESTIMATES
    • 11.2.2. KEY DRIVERS
    • 11.2.3. KEY CHALLENGES
    • 11.2.4. KEY PLAYERS
    • 11.2.5. COUNTRY ANALYSIS
      • 11.2.5.1. UNITED KINGDOM
      • 11.2.5.2. GERMANY
      • 11.2.5.3. FRANCE
      • 11.2.5.4. ITALY
      • 11.2.5.5. RUSSIA
      • 11.2.5.6. BELGIUM
      • 11.2.5.7. POLAND
      • 11.2.5.8. REST OF EUROPE
  • 11.3. ASIA-PACIFIC
    • 11.3.1. MARKET SIZE & ESTIMATES
    • 11.3.2. KEY DRIVERS
    • 11.3.3. KEY CHALLENGES
    • 11.3.4. KEY PLAYERS
    • 11.3.5. COUNTRY ANALYSIS
      • 11.3.5.1. CHINA
      • 11.3.5.2. JAPAN
      • 11.3.5.3. INDIA
      • 11.3.5.4. SOUTH KOREA
      • 11.3.5.5. INDONESIA
      • 11.3.5.6. THAILAND
      • 11.3.5.7. VIETNAM
      • 11.3.5.8. AUSTRALIA & NEW ZEALAND
      • 11.3.5.9. REST OF ASIA-PACIFIC
  • 11.4. REST OF THE WORLD
    • 11.4.1. MARKET SIZE & ESTIMATES
    • 11.4.2. KEY DRIVERS
    • 11.4.3. KEY CHALLENGES
    • 11.4.4. REGIONAL ANALYSIS
      • 11.4.4.1. LATIN AMERICA
      • 11.4.4.2. MIDDLE EAST & AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. KEY STRATEGIC DEVELOPMENTS
    • 12.1.1. MERGERS & ACQUISITIONS
    • 12.1.2. PRODUCT LAUNCHES
    • 12.1.3. PARTNERSHIPS & AGREEMENTS
    • 12.1.4. BUSINESS EXPANSIONS
  • 12.2. COMPANY PROFILES
    • 12.2.1. ANPARIO PLC
    • 12.2.2. ARCHER DANIELS MIDLAND CO (ADM)
    • 12.2.3. BASF SE
    • 12.2.4. BEHN MEYER GROUP
    • 12.2.5. BENEO GMBH
    • 12.2.6. CARGILL INC
    • 12.2.7. CHR HANSEN HOLDING A/S
    • 12.2.8. DUPONT DE NEMOURS INC
    • 12.2.9. KEMIN INDUSTRIES INC
    • 12.2.10. KONINKLIJKE DSM NV
    • 12.2.11. LALLEMAND INC
    • 12.2.12. LESAFFRE
    • 12.2.13. NEOSPARK DRUGS AND CHEMICALS PRIVATE LIMITED
    • 12.2.14. NOVUS INTERNATIONAL INC
    • 12.2.15. YARA INTERNATIONAL ASA

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - EUBIOTICS
  • TABLE 2: MAJOR LIVESTOCK DISEASES IN THE WORLD
  • TABLE 3: COUNTRIES WITH THE HIGHEST ANNUAL MEAT CONSUMPTION
  • TABLE 4: GLOBAL EUBIOTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL EUBIOTICS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL PROBIOTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL PROBIOTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL ORGANIC ACID MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL ORGANIC ACID MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL PREBIOTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL PREBIOTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL ESSENTIAL OILS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL ESSENTIAL OILS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL EUBIOTICS MARKET, BY FORM, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL EUBIOTICS MARKET, BY FORM, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL SOLID FORM/DRY FORM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL SOLID FORM/DRY FORM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL LIQUID MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL LIQUID MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL EUBIOTICS MARKET, BY PACKAGING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL EUBIOTICS MARKET, BY PACKAGING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL BULK PACKAGING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL BULK PACKAGING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL STAND-UP POUCHES/PORTION CONTROL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION
  • TABLE 25: GLOBAL STAND-UP POUCHES/PORTION CONTROL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL EUBIOTICS MARKET, BY LIVESTOCK, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL EUBIOTICS MARKET, BY LIVESTOCK, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL SWINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL SWINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL POULTRY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION
  • TABLE 31: GLOBAL POULTRY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL RUMINANTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL RUMINANTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL AQUACULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL AQUACULTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL OTHER LIVESTOCK MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL OTHER LIVESTOCK MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL EUBIOTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL EUBIOTICS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL GUT HEALTH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: GLOBAL GUT HEALTH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL IMMUNITY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 43: GLOBAL IMMUNITY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL YIELD MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: GLOBAL YIELD MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL EUBIOTICS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 49: GLOBAL EUBIOTICS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 51: GLOBAL ANIMALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL HUMANS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION
  • TABLE 53: GLOBAL HUMANS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL EUBIOTICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 55: GLOBAL EUBIOTICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 56: NORTH AMERICA EUBIOTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 57: NORTH AMERICA EUBIOTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 58: KEY PLAYERS IN NORTH AMERICA EUBIOTICS MARKET
  • TABLE 59: EUROPE EUBIOTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 60: EUROPE EUBIOTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 61: KEY PLAYERS IN EUROPE EUBIOTICS MARKET
  • TABLE 62: ASIA-PACIFIC EUBIOTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 63: ASIA-PACIFIC EUBIOTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 64: KEY PLAYERS IN ASIA-PACIFIC EUBIOTICS MARKET
  • TABLE 65: REST OF THE WORLD EUBIOTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 66: REST OF THE WORLD EUBIOTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 67: KEY PLAYERS IN REST OF THE WORLD EUBIOTICS MARKET
  • TABLE 68: LIST OF MERGERS & ACQUISITIONS
  • TABLE 69: LIST OF PRODUCT LAUNCHES
  • TABLE 70: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 71: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL EUBIOTICS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020
  • FIGURE 6: GLOBAL EUBIOTICS MARKET, BY PROBIOTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL EUBIOTICS MARKET, BY ORGANIC ACID, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL EUBIOTICS MARKET, BY PREBIOTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL EUBIOTICS MARKET, BY ESSENTIAL OILS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL EUBIOTICS MARKET, GROWTH POTENTIAL, BY FORM, IN 2020
  • FIGURE 11: GLOBAL EUBIOTICS MARKET, BY SOLID FORM/DRY FORM, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL EUBIOTICS MARKET, BY LIQUID, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL EUBIOTICS MARKET, GROWTH POTENTIAL, BY PACKAGING, IN 2020
  • FIGURE 14: GLOBAL EUBIOTICS MARKET, BY BULK PACKAGING, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL EUBIOTICS MARKET, BY STAND-UP POUCHES/PORTION CONTROL, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL EUBIOTICS MARKET, GROWTH POTENTIAL, BY LIVESTOCK, IN 2020
  • FIGURE 17: GLOBAL EUBIOTICS MARKET, BY SWINE, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL EUBIOTICS MARKET, BY POULTRY, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL EUBIOTICS MARKET, BY RUMINANTS, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL EUBIOTICS MARKET, BY AQUACULTURE, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL EUBIOTICS MARKET, BY OTHER LIVESTOCK, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL EUBIOTICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020
  • FIGURE 23: GLOBAL EUBIOTICS MARKET, BY GUT HEALTH, 2021-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL EUBIOTICS MARKET, BY IMMUNITY, 2021-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL EUBIOTICS MARKET, BY YIELD MANAGEMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL EUBIOTICS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL EUBIOTICS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
  • FIGURE 28: GLOBAL EUBIOTICS MARKET, BY ANIMALS, 2021-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL EUBIOTICS MARKET, BY HUMANS, 2021-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 31: NORTH AMERICA EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 32: UNITED STATES EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: CANADA EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: EUROPE EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 35: UNITED KINGDOM EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: GERMANY EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: FRANCE EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: ITALY EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: RUSSIA EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 40: BELGIUM EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: POLAND EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: REST OF EUROPE EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: ASIA-PACIFIC EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 44: CHINA EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 45: JAPAN EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: INDIA EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: SOUTH KOREA EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: INDONESIA EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 49: THAILAND EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 50: VIETNAM EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 51: AUSTRALIA & NEW ZEALAND EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 52: REST OF ASIA-PACIFIC EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 53: REST OF THE WORLD EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 54: LATIN AMERICA EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 55: MIDDLE EAST & AFRICA EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)